3165:HK:HK-ChinaAMC MSCI Europe Quality Hedged to USD ETF (HKD)

ETF | Others |

Last Closing

USD 17.26

Change

+0.14 (+0.82)%

Market Cap

N/A

Volume

1.00K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

-0.32 (-1.54%)

USD 146.84B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

-1.22 (-1.60%)

USD 24.81B
2823:HK iShares FTSE A50 China

-0.10 (-0.69%)

USD 21.23B
2801:HK iShares Core MSCI China ETF

-0.36 (-1.63%)

USD 20.56B
83188:HK ChinaAMC CSI 300 Index ETF

-0.90 (-2.13%)

USD 13.48B
82822:HK CSOP FTSE China A50

-0.08 (-0.63%)

USD 9.69B
9067:HK iShares Hang Seng TECH ETF

-0.01 (-1.10%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

-0.01 (-0.05%)

USD 9.22B
9010:HK iShares Core MSCI AC Asia ex J..

-0.11 (-1.46%)

USD 3.03B

ETFs Containing 3165:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.04% 48% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.04% 48% F 53% F
Trailing 12 Months  
Capital Gain 10.29% 57% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.29% 57% F 59% D-
Trailing 5 Years  
Capital Gain 39.87% 79% B- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.87% 79% B- 74% C
Average Annual (5 Year Horizon)  
Capital Gain 10.04% 84% B 72% C
Dividend Return 11.17% 84% B 71% C-
Total Return 1.13% 37% F 27% F
Risk Return Profile  
Volatility (Standard Deviation) 12.79% 70% C- 89% A-
Risk Adjusted Return 87.31% 97% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.